ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Toughens Criteria for MERIT Awards

February 23, 1996

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

AACR, ASCO, ONS Flex Political Muscles, Seek Changes In Cancer Act, Other Legislation, Funding Of Grants

May 7, 1982

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988